Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules

Endocrinology

Volumn 142, Issue 4, 2001, Pages 1479-1488

  Hadsell, D L ^a   Alexeenko, T ^a   Klemintidis, Y ^a   Torres, D ^a   Lee, A V ^a  

^a SOUTHERN PLAINS AGRICULTURAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PROTEIN KINASE; PROTEIN KINASE B; SOMATOMEDIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; FEMALE; GENE OVEREXPRESSION; INVOLUTION; MAMMARY GLAND; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 0035054181     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.4.8087     Document Type: Article

References (36)

1. Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis
2. Transcription factor activities and gene expression during mouse mammary gland involution
3. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways
4. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer
5. Delayed involution of the mammary epithelium in BALB/c-p53null mice
6. The role of prolactin and growth hormone in the regulation of casein gene expression and mammary cell survival: Relationships to milk synthesis and secretion
7. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland
8. Does an IGF-binding protein (IGFBP) present in involuting rat mammary gland regulate apoptosis?
9. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat
10. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of stat3
11. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins
12. The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin
13. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
14. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model
15. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression
16. Cooperation between des(1-3) IGF-I and mutant p53 accelerates mammary gland carcinogenesis in bigenic mice
17. A transgenic mouse model for mamary carcinogenesis
18. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
19. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
20. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
21. Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene
22. Regulation of neuronal survival by the serine-threonine protein kinase Akt
23. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
24. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by IGFs and IGF analogs
25. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs
26. Biosensor measurment of the interaction kinetics between insulin-like growth factors and their binding proteins
27. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
28. Role of IRS-1 in insulin-induced modulation of estrogen receptors in breast cancer cells
29. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′ kinase
30. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase
31. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
32. Control of milk secretion and apoptosis during mammary, involution
33. Water content of rat adipose tissue and isolated adipocytes in relation to cell size
34. Developmental regulation of murine mammary progesterone receptor gene expression
35. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteosomal degradaiont pathway
36. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26s proteosome and blocked by phosphatidylinositol 3′-kinase inhibition